Skip to content
Disclosery

ORBIMED ADVISORS LLC: EW position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on EW, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 834,900 EW shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 834,900 shares
    Change vs previous 13F -395,700 shares

    1.43% of the 13F portfolio, value $75,525,054.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,230,600 shares
    Change vs previous 13F -612,300 shares

    2.15% of the 13F portfolio, value $98,546,448.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,842,900 shares
    Change vs previous 13F +158,900 shares

    3.22% of the 13F portfolio, value $157,107,225.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,684,000 shares
    Change vs previous 13F -24,000 shares

    3.14% of the 13F portfolio, value $130,964,680.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,708,000 shares
    Change vs previous 13F +176,000 shares

    3.36% of the 13F portfolio, value $133,582,680.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,532,000 shares
    Change vs previous 13F +386,698 shares

    2.67% of the 13F portfolio, value $111,039,360.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,145,302 shares
    Change vs previous 13F not available

    1.76% of the 13F portfolio, value $84,786,707.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).